Lung Cancer News

Thermal ablation conferred OS rates comparable to those of stereotactic radiation therapy among patients with inoperable, stage I non-small cell lung cancer, according to study results.

Adverse events associated with immune checkpoint inhibitors may be more common than reported in trials that led to FDA approvals of those agents, according to a study presented at Palliative and Supportive Care in Oncology Symposium.

The FDA approved pembrolizumab in combination with carboplatin and either paclitaxel or nab-paclitaxel for first-line treatment of metastatic squamous non-small cell lung cancer.

Roswell Park Comprehensive Cancer Center and the Havana-based Center for Molecular Immunology have formed the first biotech venture between the United States and Cuba.

Researchers recently reported “significant progress” in explaining the mechanisms of asbestos carcinogenesis and of mesothelioma pathogenesis, which has allowed for novel screening and therapy targets. However, the American Cancer Society says “much remains to be learned” about the disease that more than 20 million people in the U.S. are at risk for developing due to asbestos exposure, according to one research team.

CHICAGO — First-line pembrolizumab conferred longer median OS than chemotherapy among patients with non-small cell lung cancer and PD-L1 expression, according to results of the phase 3 KEYNOTE-042 clinical trial presented during the plenary session at ASCO Annual Meeting.

The FDA granted expanded clearance to the Paxman Scalp Cooling System, allowing the device to be used by patients with any type of solid tumor.

Long-term light smokers were at greater risk for obstructive lung disease, emphysema and lung function decline than heavy smokers who quit, according to findings recently presented at the American Thoracic Society 2018 International Conference.

Palliative care appeared to reduce the risk for suicide among veterans with advanced lung cancer, according to findings presented at the American Thoracic Society International Conference.

Stereotactic radiosurgery without whole-brain radiation therapy improved survival for patients with brain metastases from small cell lung cancer, according to study results.